Friday, August 14, 2026

Silicon Valley Showdown: Microsoft, Apple, NVIDIA Vie for Market Cap Crown

Microsoft Corporation(MS), Apple, and Nvidia compete...

North Korea Constructs Five Hotels In Samjiyon City As Regime Nears Tourism Normalization Amid Forced Mobilization Of Residents

North Korea opens five new hotels in Samjiyon, aiming to boost tourism culture and establish a major tourist destination.

Did North Korea Just Try to Float a Warship with Balloons?

North Korea's new destroyer capsized during launch; analysts note balloon-like objects may be an unconventional salvage attempt.

Tag: ST Pharm

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

ST Pharm Expands Global CDMO Outreach at TIDES USA and ASGCT 2026

ST Pharm showcased its CDMO capabilities at TIDES USA and ASGCT 2026, focusing on nucleic acid therapeutics and strategic partnerships.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Top News

- Our Sponsors Ad -

Follow us